Literature DB >> 32767243

Exosomes: Dynamic Mediators of Extracellular Communication in the Tumor Microenvironment.

Kerri Wolf-Dennen1, Eugenie S Kleinerman2.   

Abstract

It is becoming increasingly recognized that the tumor microenvironment significantly contributes to the development, progression, and metastasis of cancer and also plays a role in response to treatment. The tumor microenvironment is a complex and heterogeneous niche comprised of stromal cells, cancer cells, blood vessels, areas of hypoxia and necrotic tissue, fibrosis, and extracellular matrix. Cellular communication takes place within the tumor microenvironment, both via cell to cell contact, and through extracellular mechanisms such as exosomal signaling. Exosomes are very small membrane-bound vesicles that have been shown to play key roles in the progression of cancer including modulation of the tumor microenvironment through the induction of angiogenesis, the transfer of genetic information that confers drug resistance, and increased cell migration, invasion, proliferation, and survival, as well as the modulation of immune cell interactions. The role of exosomes in several different cancers has been investigated. In the context of osteosarcoma, understanding how exosomes may modulate the tumor microenvironment to support metastatic growth particularly in the lung, the most common site of metastases, may identify novel therapeutic targets for relapsed patients.

Entities:  

Keywords:  Cell signaling; Etracellular communication; Exosomes; Extracellular vesicles; Osteosarcoma progression and metastasis; Tumor microenvironment

Mesh:

Year:  2020        PMID: 32767243     DOI: 10.1007/978-3-030-43085-6_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.

Authors:  Michelle Shen; Shiqin Liu; Tanya Stoyanova
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

2.  Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.

Authors:  Kelly M Makielski; Alicia J Donnelly; Ali Khammanivong; Milcah C Scott; Andrea R Ortiz; Dana C Galvan; Hirotaka Tomiyasu; Clarissa Amaya; Kristin A Ward; Alexa Montoya; John R Garbe; Lauren J Mills; Gary R Cutter; Joelle M Fenger; William C Kisseberth; Timothy D O'Brien; Brenda J Weigel; Logan G Spector; Brad A Bryan; Subbaya Subramanian; Jaime F Modiano
Journal:  Lab Invest       Date:  2021-09-06       Impact factor: 5.662

Review 3.  Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer.

Authors:  Ye Li; Zhuo-Kun Chen; Xu Duan; He-Jing Zhang; Bo-Lin Xiao; Kui-Ming Wang; Gang Chen
Journal:  Exp Mol Med       Date:  2022-09-18       Impact factor: 12.153

4.  Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study.

Authors:  Qi Zheng; Hanzhou Wang; Wei Hou; Ying Zhang
Journal:  Front Cardiovasc Med       Date:  2021-12-02

5.  Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.

Authors:  Linda Hofmann; Valentin Medyany; Jasmin Ezić; Ramin Lotfi; Beate Niesler; Ralph Röth; Daphne Engelhardt; Simon Laban; Patrick J Schuler; Thomas K Hoffmann; Cornelia Brunner; Edwin K Jackson; Marie-Nicole Theodoraki
Journal:  Front Med (Lausanne)       Date:  2022-07-11

6.  MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells.

Authors:  Hongqing Wen; Zhiyan Liu; Jingjing Tang; Lina Bu
Journal:  Aging (Albany NY)       Date:  2021-09-09       Impact factor: 5.682

7.  Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas.

Authors:  Charlotte Nazon; Marina Pierrevelcin; Thibault Willaume; Benoît Lhermitte; Noelle Weingertner; Antonio Di Marco; Laurent Bund; Florence Vincent; Guillaume Bierry; Anne Gomez-Brouchet; Françoise Redini; Nathalie Gaspar; Monique Dontenwill; Natacha Entz-Werle
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.